Sec. 481.0762. MONITORING BY REGULATORY AGENCY. (a) Each regulatory agency that issues a license, certification, or registration to a prescriber shall promulgate specific guidelines for prescribers regulated by that agency for the responsible prescribing of opioids, benzodiazepines, barbiturates, or carisoprodol.
(b) A regulatory agency that issues a license, certification, or registration to a prescriber shall periodically access the information submitted to the board under Sections 481.074(q) and 481.075 to determine whether a prescriber is engaging in potentially harmful prescribing patterns or practices.
(c) If the board sends a prescriber an electronic notification authorized under Section 481.0761(i), the board shall immediately send an electronic notification to the appropriate regulatory agency.
(d) In determining whether a potentially harmful prescribing pattern or practice is occurring, the appropriate regulatory agency, at a minimum, shall consider:
(1) the number of times a prescriber prescribes opioids, benzodiazepines, barbiturates, or carisoprodol; and
(2) for prescriptions described by Subdivision (1), patterns of prescribing combinations of those drugs and other dangerous combinations of drugs identified by the board.
(e) If, during a periodic check under this section, the regulatory agency finds evidence that a prescriber may be engaging in potentially harmful prescribing patterns or practices, the regulatory agency may notify that prescriber.
(f) A regulatory agency may open a complaint against a prescriber if the agency finds evidence during a periodic check under this section that the prescriber is engaging in conduct that violates this subchapter or any other statute or rule.
Added by Acts 2017, 85th Leg., R.S., Ch. 485 (H.B. 2561), Sec. 6, eff. September 1, 2017.
Structure Texas Statutes
Title 6 - Food, Drugs, Alcohol, and Hazardous Substances
Subtitle C - Substance Abuse Regulation and Crimes
Chapter 481 - Texas Controlled Substances Act
Section 481.061. Federal Registration Required
Section 481.065. Authorization for Certain Activities
Section 481.068. Confidentiality
Section 481.070. Administering or Dispensing Schedule I Controlled Substance
Section 481.074. Prescriptions
Section 481.075. Schedule Ii Prescriptions
Section 481.0755. Written, Oral, and Telephonically Communicated Prescriptions
Section 481.0756. Waivers From Electronic Prescribing
Section 481.076. Official Prescription Information; Duties of Texas State Board of Pharmacy
Section 481.0761. Rules; Authority to Contract
Section 481.0762. Monitoring by Regulatory Agency
Section 481.0763. Registration by Regulatory Agency
Section 481.07635. Continuing Education
Section 481.07636. Opioid Prescription Limits
Section 481.0764. Duties of Prescribers, Pharmacists, and Related Health Care Practitioners
Section 481.0766. Reports of Wholesale Distributors
Section 481.0767. Advisory Committee
Section 481.0768. Administrative Penalty: Disclosure or Use of Information
Section 481.0769. Criminal Offenses Related to Prescription Information
Section 481.077. Chemical Precursor Records and Reports
Section 481.0771. Records and Reports on Pseudoephedrine
Section 481.080. Chemical Laboratory Apparatus Record-Keeping Requirements